EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

OMIP‐120: A 22‐Marker Spectral Flow Cytometry Panel for the Characterization of Major Immune Populations in Murine Bone Marrow and Osteosarcoma Tissue

Simone Foderaro, Manon Mulders, Celine C E De Schrijver, Crescenzo Massaro, Alberta G A Paul, Juan J Garcia-Vallejo, Serena Rubina Baglio iD

Cytometry Part A · 2026-05 · 109 (5) · 317-349

DOI: 10.1002/cyto.a.70034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part A, online erschienen am 02.06.2026. Verfasst von Simone Foderaro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Osteosarcoma, Flow Cytometry, Bone Marrow, Bone Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumors that develop in the bone exhibit poor responses to most treatment options, including advanced immunotherapies. Despite its immune‐rich composition, the bone marrow microenvironment often fails to suppress tumor progression and instead promotes tumor growth and immune evasion, although the underlying mechanisms remain poorly understood. To investigate tumor‐induced remodeling of the bone marrow immune environment and characterize tumor‐infiltrating immune populations, we developed a high‐dimensional 22‐marker spectral flow cytometry panel for use in preclinical models of bone and bone marrow cancers. The panel enables profiling of major immune populations including CD4 + T and CD8 + T cells, B cells, Natural Killer cells, dendritic cells, monocytes, macrophages and neutrophils, and incorporates activation, exhaustion and immune checkpoint markers. Panel optimization was performed using spleen, freshly isolated bone marrow and tibial osteosarcoma tissue from adult BALB/c mice. While optimized for murine osteosarcoma and bone marrow tissue, this panel provides a robust and adaptable platform for high‐dimensional immune profiling across solid tumors and hematological malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaFlow CytometryBone MarrowBone NeoplasmsAnimalsMiceMice, Inbred BALB CTumor MicroenvironmentKiller Cells, NaturalBiomarkers, TumorHumansBone Marrow CellsFemale

Stichwörter der Autor:innen

bone marrowhigh‐dimensional spectral flow cytometryimmune suppressionosteosarcomatumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Cytek Biosciences, Inc. Scientific Commercialization, Fremont, California, USA.
  • Department of Molecular Cell Biology & Immunology, Amsterdam Institute for Immunology and Infectious Diseases and Cancer Center Amsterdam, Amsterdam, the Netherlands.

ORCID-Profile: Serena Rubina Baglio

Zitieren

APA

Foderaro, S., Mulders, M., De Schrijver, C. C. E., Massaro, C., Paul, A. G. A., Garcia-Vallejo, J. J., & Baglio, S. R. (2026). OMIP‐120: A 22‐Marker Spectral Flow Cytometry Panel for the Characterization of Major Immune Populations in Murine Bone Marrow and Osteosarcoma Tissue. Cytometry Part A, 109(5), 317-349. https://doi.org/10.1002/cyto.a.70034

Vancouver

Foderaro S, Mulders M, De Schrijver CCE, Massaro C, Paul AGA, Garcia-Vallejo JJ, et al. OMIP‐120: A 22‐Marker Spectral Flow Cytometry Panel for the Characterization of Major Immune Populations in Murine Bone Marrow and Osteosarcoma Tissue. Cytometry Part A. 2026;109(5):317-349. doi:10.1002/cyto.a.70034

BibTeX
@article{Foderaro2026,
  author = {Foderaro, Simone and Mulders, Manon and De Schrijver, Celine C E and Massaro, Crescenzo and Paul, Alberta G A and Garcia-Vallejo, Juan J and Baglio, Serena Rubina},
  title = {OMIP‐120: A 22‐Marker Spectral Flow Cytometry Panel for the Characterization of Major Immune Populations in Murine Bone Marrow and Osteosarcoma Tissue},
  journal = {Cytometry Part A},
  year = {2026},
  volume = {109},
  number = {5},
  pages = {317--349},
  doi = {10.1002/cyto.a.70034}
}
Kostenlos starten →